Literature DB >> 27453062

The potential danger of empiric antimicrobial therapy for nosocomial SBP.

Alastair O'Brien1, Louise China1, Vanya Gant1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27453062     DOI： 10.1002/hep.28733

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  2 in total

1.  Response criteria of tolvaptan for the treatment of hepatic edema.

Authors:  Yasunari Hiramine; Haruki Uojima; Hiroyuki Nakanishi; Akira Hiramatsu; Takuya Iwamoto; Mutsuumi Kimura; Hideto Kawaratani; Shuji Terai; Hitoshi Yoshiji; Hirofumi Uto; Isao Sakaida; Namiki Izumi; Kiwamu Okita; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2017-06-29       Impact factor: 7.527

2.  ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.

Authors:  Dominic Crocombe; Norin Ahmed; Indran Balakrishnan; Ekaterina Bordea; Marisa Chau; Louise China; Lynsey Corless; Victoria Danquah; Hakim-Moulay Dehbi; John F Dillon; Ewan H Forrest; Nick Freemantle; David Peter Gear; Coral Hollywood; Rachael Hunter; Tasheeka Jeyapalan; Yiannis Kallis; Stuart McPherson; Iulia Munteanu; Jim Portal; Paul Richardson; Stephen D Ryder; Amandeep Virk; Gavin Wright; Alastair O'Brien
Journal:  Trials       Date:  2022-09-27       Impact factor: 2.728
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.